rethinkTHC Search
Menu
Study breakdown

Synthetic cannabinoids contaminated with rat poison caused blood clotting disorder diagnosed via factor levels

Case ReportPreliminary evidence
The takeaway

A young adult using synthetic cannabinoids developed severe blood clotting dysfunction from coumarin contamination, with factor level testing enabling rapid diagnosis before confirmatory toxicology results.

Emergency physicians, toxicologists, and synthetic cannabinoid users.

Factor levels enabled diagnosis before confirmatory assay results

What the researchers found

A young adult presented with elevated INR without known medical history. Factor levels revealed deficiencies in factors II, VII, IX, and X, pointing to superwarfarin-type anticoagulant contamination. The patient later confirmed synthetic cannabinoid use, and bromadiolone testing was positive.

Why it matters

Coumarin-contaminated synthetic cannabinoids have caused outbreaks of life-threatening coagulopathy. This case demonstrates that factor level testing can enable rapid diagnosis when patients may not initially disclose substance use.

The numbers in context

One patient with acute INR elevation. Deficiencies in factors II, VII, IX, and X identified. Bromadiolone assay positive (confirmed after discharge). Patient initially denied substance use but later confirmed synthetic cannabinoid consumption.

How the study worked

Single case report documenting clinical presentation, diagnostic workup using coagulation factor levels, treatment, and confirmatory toxicology testing.

What this study cannot tell us

Single case report. Factor level patterns can have other causes. Confirmatory assays for toxic coumarin derivatives remain not readily available in most hospitals.

How to read the evidence

Preliminary: single case report with novel diagnostic approach.

When this study was published

Published in 2022.

The bigger picture

Synthetic cannabinoids contaminated with superwarfarins have caused mass casualty events in several US cities. Having a rapid diagnostic approach helps clinicians identify and treat this life-threatening condition.

Questions still open

  • How common is coumarin contamination in current synthetic cannabinoid supply? Should factor level testing be standard for unexplained coagulopathy in young adults? Would point-of-care superwarfarin testing improve outcomes?

Common questions

What is coumarin contamination?
Some synthetic cannabinoid products are contaminated with superwarfarins (long-acting rat poisons that prevent blood from clotting). These cause persistent and potentially life-threatening bleeding disorders.
How was the diagnosis made?
Blood coagulation factor levels showed deficiencies in factors II, VII, IX, and X, a pattern characteristic of superwarfarin exposure. The patient initially denied drug use but later confirmed synthetic cannabinoid consumption.
Is this common?
Outbreaks of coumarin-contaminated synthetic cannabinoids have been reported in several US cities, causing hundreds of cases of coagulopathy and some deaths.

Read the original research

Factor-guided diagnosis of coagulopathy associated with coumarin-contaminated synthetic cannabinoids.

The American journal of emergency medicine, 58, 350.e5-350.e6

Citation

Torian, Sterling C; Hayes, Lisa; Negrete, Ana. (2022). Factor-guided diagnosis of coagulopathy associated with coumarin-contaminated synthetic cannabinoids.. The American journal of emergency medicine, 58, 350.e5-350.e6. https://doi.org/10.1016/j.ajem.2022.05.005

Explore the wider topic